Definitive Healthcare Corp (DH)
5.475
+0.03
(+0.55%)
USD |
NASDAQ |
Jun 21, 16:00
5.475
0.00 (0.00%)
After-Hours: 16:34
Definitive Healthcare Research and Development Expense (Quarterly): 10.13M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.13M |
| December 31, 2023 | 11.57M |
| September 30, 2023 | 10.76M |
| June 30, 2023 | 10.23M |
| March 31, 2023 | 9.884M |
| December 31, 2022 | 10.13M |
| September 30, 2022 | 9.205M |
| June 30, 2022 | 8.706M |
| Date | Value |
|---|---|
| March 31, 2022 | 6.85M |
| December 31, 2021 | 5.748M |
| September 30, 2021 | 4.746M |
| June 30, 2021 | 4.277M |
| March 31, 2021 | 3.794M |
| December 31, 2020 | 3.496M |
| September 30, 2020 | 2.618M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.618M
Minimum
Sep 2020
11.57M
Maximum
Dec 2023
7.476M
Average
8.706M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Privia Health Group Inc | -- |
| Doximity Inc | 20.15M |
| Spok Holdings Inc | 2.951M |
| Ontrak Inc | 1.078M |
| FOXO Technologies Inc | -0.024M |